CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer

Abstract Background Hepatic metastasis is the primary and direct cause of death in individuals with colorectal cancer (CRC) attribute to lack of effective therapeutic targets. The present study aimed to identify potential druggable candidate targets for patients with liver metastatic CRC. Methods Th...

Full description

Bibliographic Details
Main Authors: Wei Dai, Junhong Wu, Xiaopeng Peng, Wen Hou, Hao Huang, Qilai Cheng, Zhiping Liu, Walter Luyten, Liliane Schoofs, Jingfeng Zhou, Shenglan Liu
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/ctm2.1087
_version_ 1817976121703006208
author Wei Dai
Junhong Wu
Xiaopeng Peng
Wen Hou
Hao Huang
Qilai Cheng
Zhiping Liu
Walter Luyten
Liliane Schoofs
Jingfeng Zhou
Shenglan Liu
author_facet Wei Dai
Junhong Wu
Xiaopeng Peng
Wen Hou
Hao Huang
Qilai Cheng
Zhiping Liu
Walter Luyten
Liliane Schoofs
Jingfeng Zhou
Shenglan Liu
author_sort Wei Dai
collection DOAJ
description Abstract Background Hepatic metastasis is the primary and direct cause of death in individuals with colorectal cancer (CRC) attribute to lack of effective therapeutic targets. The present study aimed to identify potential druggable candidate targets for patients with liver metastatic CRC. Methods The transcriptional profiles of super‐enhancers (SEs) in primary and liver metastatic CRC were evaluated in publicly accessible CRC datasets. Immunohistochemistry of human CRC tissues was conducted to determine the expression level of CDK12. Cellular proliferation, survival and stemness were examined upon CDK12 inhibition by shCDK12 or a selective CDK12 inhibitor named SR‐4835 with multiple in vitro and in vivo assays. RNA sequencing and bioinformatics analyses were carried out to investigate the mechanisms of CDK12 inhibition in CRC cells. Results We identified CDK12 as a driver gene for direct hepatic metastasis in CRC. Suppression of CDK12 led to robust inhibition of proliferation, survival and stemness. Mechanistically, CDK12 intervention preferentially repressed the transcription of SE‐associated genes. Integration of the SE landscape and RNA sequencing, BCL2L1 and CCDC137 were identified as SE‐associated oncogenic genes to strengthen the abilities of cellular survival, proliferation and stemness, eventually increasing liver metastasis of CRC. Conclusions Our data highlight the potential of CDK12 and SE‐associated oncogenic transcripts as therapeutic targets for patients with liver metastatic CRC.
first_indexed 2024-04-13T21:58:16Z
format Article
id doaj.art-6c5cfe2e07204a19b6cd377fbda17070
institution Directory Open Access Journal
issn 2001-1326
language English
last_indexed 2024-04-13T21:58:16Z
publishDate 2022-10-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj.art-6c5cfe2e07204a19b6cd377fbda170702022-12-22T02:28:10ZengWileyClinical and Translational Medicine2001-13262022-10-011210n/an/a10.1002/ctm2.1087CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancerWei Dai0Junhong Wu1Xiaopeng Peng2Wen Hou3Hao Huang4Qilai Cheng5Zhiping Liu6Walter Luyten7Liliane Schoofs8Jingfeng Zhou9Shenglan Liu10School of Pharmacy Gannan Medical University Ganzhou Jiangxi ChinaSchool of Pharmacy Gannan Medical University Ganzhou Jiangxi ChinaSchool of Pharmacy Gannan Medical University Ganzhou Jiangxi ChinaSchool of Pharmacy Gannan Medical University Ganzhou Jiangxi ChinaSchool of Pharmacy Gannan Medical University Ganzhou Jiangxi ChinaSchool of Pharmacy Gannan Medical University Ganzhou Jiangxi ChinaCenter for Immunology Gannan Medical University Ganzhou Jiangxi ChinaDepartment of Biology KU Leuven Leuven BelgiumDepartment of Biology KU Leuven Leuven BelgiumDepartment of Hematology and Oncology International Cancer Center Shenzhen Key Laboratory Shenzhen University General Hospital Shenzhen University Clinical Medical Academy Shenzhen University Health Science Center Shenzhen ChinaSchool of Pharmacy Gannan Medical University Ganzhou Jiangxi ChinaAbstract Background Hepatic metastasis is the primary and direct cause of death in individuals with colorectal cancer (CRC) attribute to lack of effective therapeutic targets. The present study aimed to identify potential druggable candidate targets for patients with liver metastatic CRC. Methods The transcriptional profiles of super‐enhancers (SEs) in primary and liver metastatic CRC were evaluated in publicly accessible CRC datasets. Immunohistochemistry of human CRC tissues was conducted to determine the expression level of CDK12. Cellular proliferation, survival and stemness were examined upon CDK12 inhibition by shCDK12 or a selective CDK12 inhibitor named SR‐4835 with multiple in vitro and in vivo assays. RNA sequencing and bioinformatics analyses were carried out to investigate the mechanisms of CDK12 inhibition in CRC cells. Results We identified CDK12 as a driver gene for direct hepatic metastasis in CRC. Suppression of CDK12 led to robust inhibition of proliferation, survival and stemness. Mechanistically, CDK12 intervention preferentially repressed the transcription of SE‐associated genes. Integration of the SE landscape and RNA sequencing, BCL2L1 and CCDC137 were identified as SE‐associated oncogenic genes to strengthen the abilities of cellular survival, proliferation and stemness, eventually increasing liver metastasis of CRC. Conclusions Our data highlight the potential of CDK12 and SE‐associated oncogenic transcripts as therapeutic targets for patients with liver metastatic CRC.https://doi.org/10.1002/ctm2.1087CCDC137CDK12colorectal cancerliver metastasissuper‐enhancers
spellingShingle Wei Dai
Junhong Wu
Xiaopeng Peng
Wen Hou
Hao Huang
Qilai Cheng
Zhiping Liu
Walter Luyten
Liliane Schoofs
Jingfeng Zhou
Shenglan Liu
CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer
Clinical and Translational Medicine
CCDC137
CDK12
colorectal cancer
liver metastasis
super‐enhancers
title CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer
title_full CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer
title_fullStr CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer
title_full_unstemmed CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer
title_short CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer
title_sort cdk12 orchestrates super enhancer associated ccdc137 transcription to direct hepatic metastasis in colorectal cancer
topic CCDC137
CDK12
colorectal cancer
liver metastasis
super‐enhancers
url https://doi.org/10.1002/ctm2.1087
work_keys_str_mv AT weidai cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT junhongwu cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT xiaopengpeng cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT wenhou cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT haohuang cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT qilaicheng cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT zhipingliu cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT walterluyten cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT lilianeschoofs cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT jingfengzhou cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer
AT shenglanliu cdk12orchestratessuperenhancerassociatedccdc137transcriptiontodirecthepaticmetastasisincolorectalcancer